(Q39627462)

13 September 2017

title

PKM2: a new player in the β-catenin game (English)

1 reference

13 September 2017

Frédéric Canal

1

1 reference

13 September 2017

Christine Perret

series ordinal

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

8

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

395-398

1 reference

Wnt/beta-catenin signaling in development and disease

13 September 2017

cites work

1 reference

Beta-catenin hits chromatin: regulation of Wnt target gene activation

21 January 2018

1 reference

Wnt signaling inside the nucleus

21 January 2018

1 reference

Convergence between Wnt-β-catenin and EGFR signaling in cancer

21 January 2018

1 reference

Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

21 January 2018

1 reference

Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells

21 January 2018

1 reference

Aerobic glycolysis: meeting the metabolic requirements of cell proliferation

21 January 2018

1 reference

Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance

21 January 2018

1 reference

Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

21 January 2018

1 reference

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

21 January 2018

1 reference

Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription

21 January 2018

1 reference

Pyruvate kinase M2 is a phosphotyrosine-binding protein

21 January 2018

1 reference

Apc tumor suppressor gene is the "zonation-keeper" of mouse liver

21 January 2018

1 reference

The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma

21 January 2018

1 reference

Current therapeutic paradigms in glioblastoma

21 January 2018

1 reference

β-catenin and Gli1 are prognostic markers in glioblastoma.

21 January 2018

1 reference

Wnt activation is implicated in glioblastoma radioresistance

21 January 2018

1 reference

Identification of small molecule inhibitors of pyruvate kinase M2

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.12.11

1 reference

13 September 2017

1 reference